Since 2019, the FDA has reported dozens of drug recalls because of the presence of nitrosamine, a probable carcinogen that largely pulls blood pressure treatments off the market.
Read the full post on Becker's Hospital Review - Healthcare News
6 nitrosamine drug recalls in 2022
